Arbutus Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.About ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV).
ABUS Key Statistics
Stock Snapshot
The current Arbutus Biopharma(ABUS) stock price is $4.68, with a market capitalization of 899.11M. The stock trades at a price-to-earnings (P/E) ratio of -20.74.
As of 2026-02-26, Arbutus Biopharma(ABUS) stock has fluctuated between $4.53 and $4.68. The current price stands at $4.68, placing the stock +3.2% above today's low and 0.0% off the high.
The Arbutus Biopharma(ABUS)'s current trading volume is 299.63K, compared to an average daily volume of 1.67M.
During the past year, Arbutus Biopharma(ABUS) stock moved between $2.71 at its lowest and $5.10 at its peak.
During the past year, Arbutus Biopharma(ABUS) stock moved between $2.71 at its lowest and $5.10 at its peak.
ABUS News
The latest update is out from Arbutus Biopharma ( (ABUS) ). On February 17, 2026, the U.S. District Court for the District of Delaware issued a memorandum and...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.